Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-06-25, Stock:PFE, The news for the past five days is as follows:
2019-06-18: NEWS1: Pfizer (PFE) Gains But Lags Market: What You Should Know.NEWS2: Pfizer (PFE) Gains But Lags Market: What You Should Know.NEWS3: SHAREHOLDER ALERT: WeissLaw LLP Investigates Array BioPharma Acquisition.NEWS4: Pfizer (PFE) Gains But Lags Market: What You Should Know.NEWS5: Papa John’s Auditor Swap Is Not a Good Look.NEWS6: Papa John’s Auditor Swap Is Not a Good Look.NEWS7: Papa John’s Auditor Swap Is Not a Good Look.NEWS8: Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio.NEWS9: Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio.NEWS10: Pfizer-Array Biopharma Deal Bump Up Biotech ETFs.NEWS11: Pfizer-Array Biopharma Deal Bump Up Biotech ETFs.NEWS12: Protalix (PLX) Completes Enrollment in Fabry Disease Study.NEWS13: Protalix (PLX) Completes Enrollment in Fabry Disease Study.NEWS14: Company News For Jun 18, 2019.NEWS15: Company News For Jun 18, 2019.NEWS16: Protalix (PLX) Completes Enrollment in Fabry Disease Study.NEWS17: Pfizer Invites Public to View and Listen to Webcast of July 30 Conference Call with Analysts.NEWS18: Pfizer-Array Biopharma Deal Bump Up Biotech ETFs.NEWS19: Cancer Therapy Stocks Soar After Pfizer Deal.NEWS20: Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio.NEWS21: Health Care Sector Update for 06/18/2019: BHVN, GTHX, PHAS, JNJ, PFE, ABT, MRK, AMGN.NEWS22: Health Care Sector Update for 06/18/2019: BHVN, GTHX, PHAS, JNJ, PFE, ABT, MRK, AMGN.NEWS23: Company News For Jun 18, 2019.NEWS24: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS25: 3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer&apos;s Surprise Deal.NEWS26: Shares of cancer-therapy companies skyrocket after Pfizer acquisition news.NEWS27: NHS and life sciences sector failing to work together.NEWS28: PRESS DIGEST - Wall Street Journal - June 18.NEWS29: Dow Jones Today: Almost a Case of the Mondays.NEWS30: Dow Jones Today: Almost a Case of the Mondays.NEWS31: 5 Top Stock Trades for Tuesday: FB, NFLX, GILD, TSLA.NEWS32: 5 Top Stock Trades for Tuesday: FB, NFLX, GILD, TSLA.
2019-06-19: NEWS1: Here's Pfizer's Motivation Behind Its Biggest Takeover In 3 Years.NEWS2: GSK kicks off sale of $1.2 billion consumer health drugs: sources.NEWS3: Cancer/Gene Therapy Biotechs in Focus After Pfizer-Array Deal.NEWS4: 3 Big Stock Charts for Wednesday: Pfizer, FMC and McCormick & Company.NEWS5: 3 Big Stock Charts for Wednesday: Pfizer, FMC and McCormick & Company.NEWS6: Big Drugmakers That May Tread the M&A Path After Pfizer.NEWS7: Big Drugmakers That May Tread the M&A Path After Pfizer.NEWS8: Cancer/Gene Therapy Biotechs in Focus After Pfizer-Array Deal.NEWS9: 2 Midcaps to Watch Should Pfizer-Array Deal Spark M&A Fever in Biotech Land.NEWS10: Health Care Sector Update for 06/19/2019: MLNT, CALA, MYOS, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Health Care Sector Update for 06/19/2019: MLNT, CALA, MYOS, JNJ, PFE, ABT, MRK, AMGN.NEWS12: A Beloved Biotech ETF Could Lure Traders Again.NEWS13: Big Drugmakers That May Tread the M&A Path After Pfizer.NEWS14: 3 Big Stock Charts for Wednesday: Pfizer, FMC and McCormick & Company.
2019-06-20: NEWS1: After Hours Most Active for Jun 20, 2019 :  MSFT, FAST, QQQ, BBVA, AMCR, GE, T, FDC, PFE, CSX, AMD, CMCSA.NEWS2: After Hours Most Active for Jun 20, 2019 :  MSFT, FAST, QQQ, BBVA, AMCR, GE, T, FDC, PFE, CSX, AMD, CMCSA.NEWS3: Is Pfizer Overpaying for Array Biopharma?.NEWS4: Stock Market News For Jun 20, 2019.NEWS5: Is Pfizer Overpaying for Array Biopharma?.NEWS6: Health Care Sector Update for 06/20/2019: EDSA, GHSI, IDXG, JNJ, PFE, ABT, MRK, AMGN.NEWS7: Health Care Sector Update for 06/20/2019: EDSA, GHSI, IDXG, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Stock Market News For Jun 20, 2019.NEWS9: GSK offers concessions to address EU concerns over Pfizer deal.
2019-06-21: NEWS1: Amag’s plan to bypass female libido drug pitfalls? Social media..NEWS2: Dow Jones Today: A Typical Summer Friday.NEWS3: Oh, By the Way, This Clinical Trial Didn't Work.NEWS4: Oh, By the Way, This Clinical Trial Didn't Work.NEWS5: Pfizer Receives European Commission Approval For Breast Cancer Drug TALZENNA.NEWS6: Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod.NEWS7: Arbutus Gets Clearance to Initiate Hepatitis Study, Stock Up.NEWS8: Arbutus Gets Clearance to Initiate Hepatitis Study, Stock Up.NEWS9: Dow 30 Stock Roundup: Boeing's $6.5B Air Force Contract, Pfizer to Buy Array BioPharma.NEWS10: Dow 30 Stock Roundup: Boeing's $6.5B Air Force Contract, Pfizer to Buy Array BioPharma.NEWS11: European Commission Approves TALZENNA® (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer.NEWS12: Health Care Sector Update for 06/21/2019: CTRV, OCUL, CGC, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Health Care Sector Update for 06/21/2019: CTRV, OCUL, CGC, JNJ, PFE, ABT, MRK, AMGN.NEWS14: Dow 30 Stock Roundup: Boeing's $6.5B Air Force Contract, Pfizer to Buy Array BioPharma.NEWS15: Arbutus Gets Clearance to Initiate Hepatitis Study, Stock Up.NEWS16: Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod.
2019-06-24: NEWS1: Why These Innovative Biotech ETFs Soaring.NEWS2: Why These Innovative Biotech ETFs Soaring.NEWS3: Comparing PFE’s and BMY’s Revenue Trajectory.NEWS4: Why These Innovative Biotech ETFs Soaring.NEWS5: This Biotech Stock Is Facing A 'Whale' As Pfizer Unveils Gene Therapy Data.NEWS6: What Analysts Recommend for Pfizer and Bristol-Myers Squibb.NEWS7: BioMarin Gets $15M From Pfizer on Talzenna's European Nod.NEWS8: BioMarin Gets $15M From Pfizer on Talzenna's European Nod.NEWS9: U.S. Senate Takes on Big Tech, Plus &quot;Merger Monday&quot;.NEWS10: Eldorado to Buy Caesars.NEWS11: Pfizer's Talzenna Gets Approval in Europe for Breast Cancer.NEWS12: Pfizer's Talzenna Gets Approval in Europe for Breast Cancer.NEWS13: Read This Before You Buy Any New Cancer Drug Stocks.NEWS14: Read This Before You Buy Any New Cancer Drug Stocks.NEWS15: BioMarin Gets $15M From Pfizer on Talzenna's European Nod.NEWS16: U.S. Senate Takes on Big Tech, Plus &quot;Merger Monday&quot;.NEWS17: Pfizer's Talzenna Gets Approval in Europe for Breast Cancer.

Answer: Rise